$48.99
PT-141 and Oxytocin are provided in a dual-compound spray format for research involving peptide classification, receptor interaction, and formulation analysis. Each unit contains 5 mg of each compound. This product is intended strictly for laboratory research use only and is not for human or veterinary use.
PT-141 (Bremelanotide) is a cyclic peptide analogue, while Oxytocin is a naturally occurring nonapeptide with a defined disulfide bond structure. Both are indexed in PubChem with detailed molecular and structural data supporting peptide classification and analytical research. [1][52
These compounds are often studied in laboratory settings for differences in peptide configuration, including cyclic versus linear structures, and their influence on molecular conformation and stability [1][2].
PubChem associates PT-141 and oxytocin with distinct receptor targets, making them relevant for studies involving ligand-receptor interaction modeling. In spray format, this product may be used in research evaluating solution stability, compound compatibility, and delivery-system characteristics [1][2].
This product is meant only for research use. It is made for lab testing and in vitro experiments (outside a living body), not for use in people or animals. All information on this website is for learning purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. It should only be used by trained professionals in a proper lab setting. This product is not a medicine, food, or cosmetic, and must not be sold or used as one.
